Delivery Order SPE2DB24D2205-SPE2DB25FEBMY

Award Date 4/25/25
Potential Completion Date 4/28/25
Potential Value $27K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award SPE2DB22D1017|SPE2DB25FG0JZ was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,949,076 units of Terbinafine HCL 250 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,982.21 and an ultimate completion date of April 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,186.62, is a delivery order for the supply of 4,567,039,299 units of Terbinafine HCL 250 mg tablets. The contract has a firm fixed price and an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DX15D3020|SPE2DX25FPYTT, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $24,394.23 firm fixed-price delivery order is for the supply of 4,566,748,972 tablets of Terbinafine HCl 250 mg. The contract has an ultimate completion date of December 18, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, is delivering these medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,239,342 units of the drug Terbinafine HCL 250 mg Tablet, with a ceiling value of $12,921.16. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an Ultimate Completion Date of May 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FG0NT, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,426.98 firm fixed-price delivery order is for the supply of 4,567,967,313 tablets of Terbinafine HCL 250 mg, a medication used to treat fungal infections. The contract has an ultimate completion date of April 21, 2025 and was awarded on April 18, 2025. This award is not associated with a set-aside program....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,926,197 units of Terbinafine HCL 250 mg tablets, a prescription medication, with a ceiling value of $1,269.85. The contract is a firm fixed-price delivery order with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $8,773.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,187,358 units of the prescription medication Terbinafine HCL 250 mg tablets, with a final completion date of May 9, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,971.41 firm fixed-price delivery order is for the supply of 4,568,188,746 units of the prescription medication terbinafine hydrochloride 250 mg tablets. The contract has a performance period through May 9, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FVL96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,837.26 firm fixed-price delivery order is for the supply of 4,568,078,153 units of the prescription medication terbinafine hydrochloride 250 mg tablets. The contract has an ultimate completion date of April 30, 2025 and was awarded on April 29, 2025. This award is not designated as a set-aside contract....
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,224.92 firm fixed price delivery order is for the supply of Terbinafine HCL 250 mg tablets, a medication used to treat fungal infections. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FEBMY
    Delivery Order

This federal contract award, with ID SPE2DB24D2205|SPE2DB25FEBMY, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,077.02 firm fixed-price delivery order is for the supply of 4,568,039 units of Terbinafine HCL 250 mg tablets, with an ultimate completion date of April 28, 2025.

Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order is not designated as a set-aside contract.

Generated 7/25/25, 11:16 AM